“I have known Ron Trahan for many years and have worked with him closely and continuously
during that time. He is creative, dedicated, and results-driven. I would highly recommend him and his firm to any emerging medtech company.”
Pierre Jérôme, Co-Founder and CEO, SpineGuard®
“I have worked with Ronald Trahan Associates almost continuously over the past 15 years in
my position as CEO of five different start-up companies. I can say, unequivocally, that Trahan’s
firm is the perfect and cost-effective PR complement to an emerging medtech company.”
John A. Williams, Serial CEO
“Like many medtech start-ups, we need the right kind of steady exposure to drive
fundraising efforts and product sales, but we cannot afford a big budget for PR services. Nevertheless, Ron Trahan and his group have demonstrated to us that we are a very important part of their business, and they have done so on a modest budget.”
Barry Russell, CEO, neoSurgical Inc.
© 2018 Ronald Trahan Associates, Inc.
“I am very impressed by Ron Trahan’s willingness to roll up his sleeves and get the job done,
day-in and day-out. Best of all, he makes good things happen while requiring no extra effort from us.”
J. Brent Ratz, Co-Founder, CardiAQ Valve Technologies
Aquired by Edwards Life Sciences in 2015
We are big believers that Success is the consequence of Process—of surefire methods which, when capably applied, produce certain Predictable Results that "inform" and "persuade," earning visibilty and credibility among target audiences.
“Ron Trahan and his group are consummate medtech PR professionals who know how to effectively and efficiently serve an OUS-based company from their headquarters near Boston.
I highly recommend RTA.”
Georg Matheis, MD, Co-Founder and Managing Director, XENiOS GmbH
“Ronald Trahan Associates provided us with savvy positioning and communication guidance
at an affordable price. RTA’s efforts most assuredly enhanced our company’s visibility and credibility, putting us in a position to raise funds and, ultimately, complete an exceptional
exit for our investors.”
Wolfgang Goetz, MD, Co-Founder and CEO, Transcatheter Technologies GmbH